NCT00165334View on ClinicalTrials.gov

Cetuximab and Vinorelbine in Elderly Subjects With Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

Cetuximab

DRUG

Vinorelbine (Navelbine)

Trial Locations (3)

02114

Massachusetts General Hospital, Boston

02115

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Massachusetts General Hospital

OTHER

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER